Biotechnology Market Research Reports
Sort By
| Title | Published | Price | Buy Now |
|---|---|---|---|
| Anti-CD80 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD80 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD80 Antibody development. The report provides detailed cov... |
Jan 2019 | $ 1250 | |
| Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Dickkopf-1 (Dkk-1) Antibody development. The ... |
Jan 2019 | $ 1250 | |
| Anti-Lymphotoxin - Pipeline Insight, 2019
By Delve Insight
"Anti-Lymphotoxin - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Lymphotoxin development. The report provides detailed coverag... |
Jan 2019 | $ 1250 | |
| Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Mucin 1 (MUC1) Antibody development. The report p... |
Jan 2019 | $ 1250 | |
| Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Apolipoprotein B (ApoB) Inhibitor development. Th... |
Jan 2019 | $ 1250 | |
| ATPase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"ATPase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "ATPase Inhibitor development. The report provides detailed coverag... |
Jan 2019 | $ 1250 | |
| Aurora Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Aurora Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Aurora Kinase Inhibitor development. The report provides de... |
Jan 2019 | $ 1250 | |
| Autophagy modulators - Pipeline Insight, 2019
By Delve Insight
"Autophagy modulators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Autophagy modulators development. The report provides detailed... |
Jan 2019 | $ 1250 | |
| Beta Secretase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Beta Secretase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Beta Secretase Inhibitor development. The report provides ... |
Jan 2019 | $ 1250 | |
| C1 Esterase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"C1 Esterase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "C1 Esterase Inhibitor development. The report provides detail... |
Jan 2019 | $ 1250 | |
| Cannabinoid Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Agonist development. The report provides detailed c... |
Jan 2019 | $ 1250 | |
| Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 1 (CB1) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 1 (CB1) Agonist... |
Jan 2019 | $ 1250 | |
| Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 1 (CB1) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 1 (CB1) Anta... |
Jan 2019 | $ 1250 | |
| Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2019
By Delve Insight
"Cannabinoid Receptor Type 2 (CB2) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cannabinoid Receptor Type 2 (CB2) Agonist... |
Jan 2019 | $ 1250 | |
| Carbonic Anhydrase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Carbonic Anhydrase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Carbonic Anhydrase Inhibitor development. The report p... |
Jan 2019 | $ 1250 | |
| Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Carnitine Palmitoyltransferase I (CPT 1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Carnitine Palmitoyltransferase I... |
Jan 2019 | $ 1250 | |
| Cathepsin K/S Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cathepsin K/S Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cathepsin K/S Inhibitor development. The report provides de... |
Jan 2019 | $ 1250 | |
| CCR1 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR1 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR1 Inhibitor development. The report provides detailed coverage of... |
Jan 2019 | $ 1250 | |
| CCR3 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR3 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR3 Inhibitor development. The report provides detailed coverage of... |
Jan 2019 | $ 1250 | |
| CCR4 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR4 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR4 Inhibitor development. The report provides detailed coverage of... |
Jan 2019 | $ 1250 | |
| CCR5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR5 Inhibitor development. The report provides detailed coverage of... |
Jan 2019 | $ 1250 | |
| CD 19 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 19 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 19 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD 33 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 33 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 33 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD 40 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 40 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 40 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD152 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD152 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD152 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 |